Royal Bank Of Canada Akoya Biosciences, Inc. Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 1,011 shares of AKYA stock, worth $1,011. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,011
Previous 1,798
43.77%
Holding current value
$1,011
Previous $4,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AKYA
# of Institutions
65Shares Held
12.4MCall Options Held
40.4KPut Options Held
1K-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$4.7 Million6.47% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$1.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.39MShares$1.39 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX671KShares$671,0002.35% of portfolio
-
Geode Capital Management, LLC Boston, MA567KShares$566,9820.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $37.9M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...